Form 4: Genprex CEO Ryan Confer Acquires Restricted Stock Units

Genprex CEO Ryan Confer was granted 29,375 restricted stock units (RSUs) that vest on June 30, 2025.

Summary

• Ryan Confer, the President, CEO, and CFO of Genprex, Inc., received 29,375 restricted stock units (RSUs) on December 5, 2024.
• These RSUs were granted under the company's 2018 Equity Incentive Plan.
• The RSUs will vest 100% on June 30, 2025, provided Mr. Confer remains a service provider to the company.
• Upon vesting, each RSU will convert into one share of Genprex common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation event, which is generally positive for aligning management and shareholder interests. There are no negative implications.

Positives

• The grant of RSUs aligns the CEO's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CEO.

Risks

• The vesting of the RSUs is contingent on continued service, which introduces a risk of forfeiture if the CEO leaves the company before the vesting date.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Industry Context

This is a standard practice for incentivizing executives in publicly traded companies, aligning their interests with those of shareholders through equity-based compensation.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) as part of executive compensation is a common practice across the biotechnology and pharmaceutical industries.
• Companies like Amgen, Gilead Sciences, and Regeneron Pharmaceuticals also utilize RSUs to incentivize their executives.
• The vesting period of approximately six months is relatively standard for such grants.

Stakeholder Impact

• The RSU grant aligns the CEO's interests with those of shareholders, potentially leading to increased value.
• The vesting schedule encourages long-term commitment from the CEO, which can benefit the company and its stakeholders.

Key Dates

Keywords

restricted stock units, RSU, equity incentive plan, insider trading, executive compensation, Genprex, GNPX, Ryan Confer